New designer drug found in Toronto fentanyl supply

Toronto: A highly potent synthetic opioid belonging to a new class of designer drugs has been detected in fentanyl samples circulating in Toronto’s illicit drug market, according to reports. Toronto’s Drug Checking Service announced that this is the sixth novel chemical substance found in the city’s fentanyl supply so far this year. Concerns are mounting that such adulterants mixed into street drugs are driving Canada’s ongoing overdose crisis.

The new substance was first detected in four fentanyl samples collected in October. Karen McDonald, executive director of the Drug Checking Service operating out of St. Michael’s Hospital, stated that the drug is so new it does not even have a generic name yet. It has been identified as either N’-Phenethyl-5-chloro nor-orphine or N’-Phenethyl-6-chloro nor-orphine. Due to their close chemical similarity, experts have not yet been able to differentiate between the two. The same substance has also been detected in Vancouver.

Unknown Potency and Side Effects

This drug belongs to the ‘orphine’ class of opioids, which global anti-drug agencies have been closely monitoring. Late last year, an orphine-class drug called ‘cychlorphine’—believed to be ten times more potent than fentanyl—was discovered in Toronto. However, because no research has been conducted on the new substance found in October, its exact potency and physiological effects remain unknown, McDonald noted. She added that this discovery highlights just how dangerously the unregulated fentanyl market is evolving.

Dangerous Interactions with Other Drugs

Cristiana Stefan, lab director at the Centre for Addiction and Mental Health (CAMH), expressed concern over how this new orphine drug interacts when mixed with other substances. Stefan and her team identified the new chemical after weeks of complex laboratory analysis.

According to the report, 96 per cent of the drugs sold as fentanyl in Toronto are adulterated with veterinary tranquillizers or benzodiazepines such as Xanax. Additionally, 83 per cent of the samples contained multiple high-potency opioids.

Death Rates and Drug Cartel Tactics

Deaths resulting from the consumption of multiple mixed substances are rising across Canada. According to data from the Public Health Agency of Canada, the proportion of overdose deaths involving three or more substances rose from 20 per cent in 2018 (491 deaths) to 42 per cent by 2023 (over 1,500 deaths).

Experts point out that as law enforcement tightens, drug manufacturers constantly experiment with new chemical combinations to cut costs and evade detection. Dan Werb, an epidemiologist at St. Michael’s Hospital, explained that since fentanyl replaced heroin as the dominant street drug, it has become possible for anyone to manufacture these substances in clandestine labs worldwide.

Drug traffickers also adjust the potency of their products based on consumer reactions. For instance, ‘carfentanil’—an opioid 100 times stronger than fentanyl—was linked to 20 per cent of overdose deaths in 2019, but manufacturers reduced its use as fatalities spiked, bringing its involvement down to three per cent by 2024. Although Canada has recorded a slight decline in overdose deaths since 2023, Dan Werb warns that the emergence of ultra-potent drugs like ‘orphine’ could worsen the situation again at any moment.

Leave a Reply

Your email address will not be published. Required fields are marked *